Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Fei Jing

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The American Journal of Case Reports|February 18, 2026
Retroperitoneal Bronchogenic Cysts: A Case SeriesShu-Xin Jing, Zhi-Fei Jing
Molecular Oncology|July 12, 2019
Inhibition of miR-34a-5p can rescue disruption of the p53-DAPK axis to suppress progression of clear cell renal cell carcinomaZhi-Fei Jing, Jian-Bin Bi, Zeliang Li, et al.
Oncotargets and Therapy|May 3, 2019
miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axisZhi-Fei Jing, Jian-Bin Bi, Ze-Liang Li, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The American Journal of Case Reports|February 18, 2026
Retroperitoneal Bronchogenic Cysts: A Case SeriesShu-Xin Jing, Zhi-Fei Jing
Molecular Oncology|July 12, 2019
Inhibition of miR-34a-5p can rescue disruption of the p53-DAPK axis to suppress progression of clear cell renal cell carcinomaZhi-Fei Jing, Jian-Bin Bi, Zeliang Li, et al.
Oncotargets and Therapy|May 3, 2019
miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axisZhi-Fei Jing, Jian-Bin Bi, Ze-Liang Li, et al.
Pageof 1